aka, Japan.
[14C]SM-7338 (27.5 mCi/mmol) was supplied by Sumitomo Chemical Co., Ltd., Osaka, Japan.
[14C]benzylpenicillin (potassium salt; 59 mCi/mmol) was purchased from the Radiochemical Centre, Amersham, England.
S. aureus FDA209P was used in the PBP experiments. The MIC was determined by the broth macrodilution method, using tryptic soy broth (Difco Laboratories, Detroit, Mich.) and a final inoculum of 106 CFU/ml. S. aureus cell membranes were prepared as previously described (20) , with some modification. S. aureus grown to late-exponential phase was harvested, and cells were broken by lysostaphin (Sigma Chemical Co., St. Louis, Mo.) treatment and sonication. The membrane fractions were pelleted by ultracentrifugation, adjusted to a concentration of 20 mg of proteins per ml, and stored at -80°C until they were used in binding experiments. The first method used for PBP analysis, a competition assay with [14C]benzylpenicillin, was essentially the same as that described by Spratt (17) , with some modifications (5, 12) . The membranes were incubated with SM-7338 or imipenem at various concentrations for 10 min at 30°C; subsequently, [14C]benzylpenicillin was added to a final concentration of 30 ,ug/ml, and incubation was continued for another 10 min. Reactions were terminated by adding a mixture consisting of nonradioactive benzylpenicillin and sodium dodecyl sulfate and heating the preparation in a boiling water. The second assay was a direct assay with radioactive SM-7338. The membranes were incubated with * Corresponding author.
[14C]SM-7338 at various concentrations for 10 min at 30°C. The subsequent procedure was the same as in the competition assay. For determining the release of SM-7338 from PBP-SM-7338 complexes, membranes were labeled with
[14C]SM-7338 at a final concentration of 3 pug/ml for 10 min at 30°C; subsequently, a 100-fold excess of nonradioactive SM-7338 was added (final concentration, 300 jxg/ml), and samples were taken at intervals during incubation at 30°C and added immediately to tubes containing sodium dodecyl sulfate. The samples were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and detected by fluorography, as described previously (20, 21) . The relative band densities on the fluorogram were determined by using a scanning densitometer with peak integration.
The affinities of SM-7338 and imipenem for PBPs of S. aureus were investigated by using the competition assay with ['4C]benzylpenicillin (Table 1 Therefore, we examined the release of bound SM-7338 from PBPs. SM-7338 was dissociated from PBP-SM-7338 complexes with half-lives of 2 min for PBP 3 and 40 min for PBP 2 (Fig. 2) . We also detected the release of SM-7338 from PBP 1 with a long half-life (>120 min), but no release from PBP 4 was observed. These results indicated that in the competition assay PBP-SM-7338 complexes were broken NOTES and benzylpenicillin and cephalothin were also dissociated with half-lives of 30 to 40 min. Hashizume et al. (7) demonstrated the release of bound imipenem from PBPs 1, 2, and 3, and they measured the release of imipenem not from each PBP but from these PBPs as the total PBPs. Further studies could not be performed because we had no radioactive imipenem available.
PBPs 5 and 6 of Escherichia coli (17) and PBP 5 of Pseudomonas aeruginosa (12) (17) . These results indicate that the dissociation of bound antibiotics from PBPs depends on the organisms, PBPs, and antibiotics. In S. aureus, PBPs 1, 2, and 3 have a releasing activity for SM-7338, whereas the ,B-lactamase activity of PBP 4 is not active on SM-7338.
